Hyundai invests in Aurora to develop driverless Kia & Hyundai models
Category: #business  By Mateen Dalal  Date: 2019-06-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

Hyundai invests in Aurora to develop driverless Kia & Hyundai models
  • The investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai vehicle models.
     
  • The Hyundai investment brings the total funding raised by the startup to approximately $700 million.

Hyundai Motor Company (Hyundai), a renowned South Korean multinational automobile manufacturer, has reportedly announced that it has invested in driverless car software startup, Aurora Innovation, Inc. (Aurora).

Reports cite, the investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai automobiles models. The Hyundai investment brings the total funding raised by the startup to approximately $700 million.

According to a press release by Aurora, the investment is an extension to an existing partnership agreement that exists between Aurora and Hyundai & Kia that focuses on integrating Aurora Driver into Hyundai’s fuel-cell powered flagship vehicle, NEXO.

The Co-Founder & Chief Product Officer of Aurora, Sterling Anderson stated that the company’s primary aim is to work alongside its partners to bring the benefits of self-driving technology to more vehicles quickly, safely and broadly.

The investment does not make the company’s driverless technology exclusive to Hyundai and Kia and the startup aims to facilitate its innovative system to many different automobile industry players.

Recently, Aurora also signed a partnership agreement with Fiat Chrysler Automobiles to develop driverless vehicles for its corporate clients. Meanwhile, it is also working with a China-based electric vehicle manufacturer, Byton.

For the record, Aurora utilizes LIDAR or light detection and ranging sensors in its autonomous driving systems. The company’s approach is completely different than Tesla’s, which employs radar and cameras to primarily drive its Tesla Autopilot features.

Reportedly, apart from Hyundai, the list of the company’s investors also includes names such as Sequoia, Greylock, T. Rowe Price, Shell Energy’s venture capital group and tech giant Amazon.

According to reports, the total size of Hyundai’s investment in Aurora has not been disclosed yet.

 

Source:

https://www.cnbc.com/2019/06/12/hyundai-backs-aurora-to-bring-driverless-systems-to-kia-hyundai-cars.html

https://medium.com/aurora-blog/hyundai-and-kia-invest-in-aurora-6e1afbde609b

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Microsoft to fix an active security flaw in Internet Explorer
Microsoft to fix an active security flaw in Internet Explorer
By Mateen Dalal

Microsoft, the renowned American tech giant, reportedly verified the presence of a security flaw that is affecting Internet Explorer (IE) and is being used by hackers. The company also said it is working to find a fix for this bug, which would be rel...

Dermtech signs a commercial & medicare advantage coverage agreement
Dermtech signs a commercial & medicare advantage coverage agreement
By Mateen Dalal

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detect...

CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
By Mateen Dalal

The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-001 respectively U.S.-based bioscience firm CoImmune, Inc., announces partnership with Formula Phar...